Back to results
US 2013/0296294 A1Published application
Treatment and/or prevention of parkinson's disease dementia with ceftriaxone
AssigneesTL & GM Chemical Company, Chung Shan Medical University
InventorYing-Jui HO
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for treatment of a human subject having or suspected of having Parkinson's disease dementia, which includes administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject.
Claims6
A method for treating a human subject having or suspected of having Parkinson's disease dementia, comprising administering to the human subject ceftriaxone at a daily dosage ranging from about 1.5 mg to about 35 mg per kilogram of a body weight of the human subject.
Dependencies are inferred from the claim text.